The major investigated parameters were the BC aneuploidy rates in relation to tumor stage, size, lymph node metastasis, grading, estrogen receptor (ER) status, disease-free survival (DFS), and overall survival (OS). The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.